shutterstock_669566830 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

BISCAY Imfinzi trial: A novel treatment approach in bladder cancer

BISCAY is a personalized clinical trial looking at different combinations of AstraZeneca’s Imfinzi (durvalumab) in platinum-refractory urothelial cancer.